Franklin Resources Inc Macrogenics Inc Transaction History

Franklin Resources Inc

$313 Billion
Q2 2024

A detailed history of Franklin Resources Inc transactions in Macrogenics Inc stock. As of the latest transaction made, Franklin Resources Inc holds 108,131 shares of MGNX stock, worth $356,832. This represents 0.0% of its overall portfolio holdings.

Number of Shares

108,131

Previous 315,272 65.7%

Holding current value

$356,832

Previous $4.64 Million 90.11%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$3.31 - $18.51 $685,636 - $3.83 Million	-207,141 Reduced 65.7%	108,131 $459,000
Q1 2024 May 13, 2024	BUY	$9.77 - $21.47 $2.52 Million - $5.53 Million	257,425 Added 445.01%	315,272 $4.64 Million
Q4 2023 Feb 09, 2024	BUY	$4.48 - $10.11 $53 - $121	12 Added 0.02%	57,847 $556,000
Q3 2023 Nov 13, 2023	SELL	$4.48 - $6.19 $30,020 - $41,479	-6,701 Reduced 10.38%	57,835 $269,000
Q2 2023 Aug 11, 2023	BUY	$4.62 - $7.54 $139,981 - $228,454	30,299 Added 88.5%	64,536 $345,000
Q1 2023 May 12, 2023	BUY	$4.82 - $7.24 $438 - $658	91 Added 0.27%	34,237 $245,000
Q4 2022 Feb 10, 2023	BUY	$3.34 - $6.98 $120 - $251	36 Added 0.11%	34,146 $229,000
Q3 2022 Nov 14, 2022	BUY	$3.01 - $5.22 $102,671 - $178,054	34,110 New	34,110 $118,000
Q2 2019 Aug 14, 2019	SELL	$14.51 - $19.71 $6.66 Million - $9.05 Million	-459,335 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$19.26 - $23.46 $390,592 - $475,768	-20,280 Reduced 4.23%	459,335 $9.85 Million
Q2 2018 Aug 14, 2018	BUY	$19.78 - $24.67 $2,274 - $2,837	115 Added 0.02%	479,615 $9.9 Million
Q4 2017 Feb 14, 2018	SELL	$16.19 - $20.3 $362,656 - $454,720	-22,400 Reduced 4.46%	479,500 $9.11 Million
Q3 2017 Nov 13, 2017	BUY	$15.52 - $18.94 $7.79 Million - $9.51 Million	501,900	501,900 $9.28 Million

Others Institutions Holding MGNX

# of Institutions

154

Shares Held

60.6M

Call Options Held

218K

Put Options Held

259K

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $203M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account

Franklin Resources Inc Macrogenics Inc Transaction History